OXFORD BIOMEDICA (OXB): MODERATED CHART AND DISCUSSION THREAD

Tuco - Fair enough, if that was an honest opinion of what level you thought the SP would reach. Equally well, we should be tolerant of those who are pessimistic in their predictions. As it happens, I believe that Gnomet's assessment of the Trovax trial data was overly pessimistic and agree with your rebuttal of his views.

I am still confident of a big rise this year - partly because of the expected good deal with Trovax and partly because biotech companies seem to be flavour of the year (2007). Whether OXB do get taken over in 2007 is not an issue as I am sure the shares will be buoyed by the takeover speculation in the whole sector.

ROL - you are gratuitously offensive again and fail to answer my post.